Novo Nordisk

Jacob Sten Petersen, Ph.D., Corporate VP, Head of Stem Cell R&D
Copenhagen, Denmark
(NYSE: NVO)
For almost 100 years, Novo Nordisk has been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines and delivery systems. From our labs to our factory floors, we are discovering and developing innovative biological medicines and making them accessible to patients throughout the world. Our focus is on the serious chronic diseases that affect hundreds of millions of people and are among the most urgent global health challenges. By combining our innovation and commercial excellence, we draw upon insights from patients and partners to transform bold ideas into life-saving and preventive medicines. We make long-term investments in novel treatments and technologies, including curative stem cell-based therapies, to continually advance the development of medical devices and digital health solutions. www.novonordisk.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions